FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients
Hematological Oncology,Volume 36, Issue 1, Page 299-306, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - August 3, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 299-306, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - August 3, 2017 Category: Hematology Source Type: research
Spectrum and immunophenotyping of 653 patients with B ‐cell chronic lymphoproliferative disorders in China: A single‐centre analysis
Hematological Oncology,Volume 36, Issue 1, Page 121-127, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 28, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 121-127, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 28, 2017 Category: Hematology Source Type: research
Epstein ‐Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma
Hematological Oncology,Volume 36, Issue 1, Page 182-188, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 26, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 182-188, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 26, 2017 Category: Hematology Source Type: research
Mean platelet volume predicts prognosis in patients with diffuse large B ‐cell lymphoma
Hematological Oncology,Volume 36, Issue 1, Page 104-109, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 23, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 104-109, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 23, 2017 Category: Hematology Source Type: research
Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat
Hematological Oncology,Volume 36, Issue 1, Page 360-362, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 21, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 360-362, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 21, 2017 Category: Hematology Source Type: research
Epstein ‐Barr virus lytic cycle involvement in diffuse large B cell lymphoma
Hematological Oncology,Volume 36, Issue 1, Page 98-103, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 14, 2017 Category: Hematology Source Type: research
Relationship between response rates and median progression ‐free survival in non‐Hodgkin's lymphoma: A meta‐analysis of published clinical trials
Hematological Oncology,Volume 36, Issue 1, Page 37-43, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 14, 2017 Category: Hematology Source Type: research
Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience
Hematological Oncology,Volume 36, Issue 1, Page 116-120, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 14, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 98-103, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 14, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 37-43, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - July 14, 2017 Category: Hematology Source Type: research
